Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial

NCT06812637 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Foot Ulcer (DFU)
Exosomes

Interventions

DRUG: WJ-MSC- Exosomes
COMBINATION_PRODUCT: SOC (Standard of care)
OTHER: Vehicle (placebo)

Sponsor

Kafrelsheikh University